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Abstract
RIG-I-like receptors detect viral RNA in infected cells and promote oligomerization of the
outer mitochondrial membrane protein MAVS to induce innate immunity to viral infection
through type I interferon production. Mitochondrial reactive oxygen species (mROS) have
been shown to enhance anti-viral MAVS signalling, but the mechanisms have remained
obscure. Using a biochemical oligomerization-reporter fused to the transmembrane domain
of MAVS, we found that mROS inducers promoted lipid-dependent MAVS transmembrane
domain oligomerization in the plane of the outer mitochondrial membrane. These events
were mirrored by Sendai virus infection, which similarly induced lipid peroxidation and pro-
moted lipid-dependent MAVS transmembrane domain oligomerization. Our observations
point to a role for mROS-induced changes in lipid bilayer properties in modulating antiviral
innate signalling by favouring the oligomerization of MAVS transmembrane domain in the
outer-mitochondrial membrane.
Introduction
Detection of viruses by pathogen associated molecular pattern (PAMP) receptors leads to the
secretion of type I interferons (IFN), which bind to IFN receptors and stimulate the expression
of genes that inhibit virus replication and spread. Detection of viral nucleic acids by Toll-like
receptors and RIG-I-like receptors (RLRs) initiates this antiviral innate immune response [1].
RLRs comprise RIG-I, which binds to viral 5’-triphosphate RNA, MDA5, which detects viral
double stranded RNA, and LGP2, which regulates RIG-I and MDA5 signalling. Binding of
viral RNA to RIG-I and MDA5 triggers a conformational change in these proteins that exposes
their Caspase Activation and Recruitment Domains (CARD). RIG-I and MDA5 subsequently
bind to and activate the mitochondrial antiviral signalling protein (MAVS, also known as IPS-
1, VISA, and CARDIF), presumably via the interaction of the RLR CARD domain with MAVS
CARD domain [2]. MAVS undergoes RLR-induced formation of higher order structures
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ranging from dimers to prion-like aggregates that lead to the recruitment and activation of sig-
nalling proteins culminating in the activation of the transcription factors IRF-3 and NF-κB
and transcription of IFNs [3].
MAVS is a tail-anchored membrane protein inserted in the outer mitochondrial membrane
(OMM), and is also found in the peroxisomal membrane and the mitochondrial associated
membrane of the endoplasmic reticulum [4,5]. The localization of MAVS seems to contribute
to the regulation of downstream signalling, as peroxisomal MAVS has been implicated in the
early type III IFN-dependent antiviral response, while mitochondrial MAVS was shown to
mediate a longer lasting type I IFN dependent antiviral response [4,6]. These observations sug-
gest that the specific protein or lipid composition of organelles or specific organelle-associated
functions could modulate MAVS function. The mitochondrial protein mitofusin 1 (MFN1)
has for example been shown to interact with MAVS and potentiate antiviral innate immune
signalling [7,8]. Further evidence suggests that MAVS signalling is promoted by mitochondrial
fusion and inhibited by mitochondrial fission, highlighting an enigmatic link between mito-
chondrial dynamics and MAVS signalling [7,9]. Mitochondrial membrane potential also mod-
ulates MAVS signalling by an unknown mechanism [10].
Because of their link to inflammation [11,12], mitochondrial reactive oxygen species
(mROS) have emerged as particularly interesting members of this growing list of mitochon-
drial signals that modulate MAVS signalling [13,14]. Mitochondria are an important source of
reactive oxygen species (ROS), which can be considered as by-products formed during the
transfer of electron through the respiratory chain [15]. ROS oxidize proteins, nucleic acids and
lipids, thereby impairing or modifying the function of these targets [16]. ROS are not merely
destructive chemical agents, they have also important physiological roles as signalling mole-
cules [17]. ROS have been shown to modulate innate immune signalling by activating p38
MAPK and promoting TRAF3-6 glutathionylation [18,19]. How mROS promote MAVS-medi-
ated type I IFN production remains however unknown.
ROS are extremely reactive towards double bonds of unsaturated fatty acids causing the
addition of a peroxyl radical in the acyl chain and displacing the double bond; a process called
lipid peroxidation [20]. The incorporation of a peroxyl radical into the acyl chain dramatically
changes its chemical nature, as the peroxyl radical is hydrophilic, while the acyl chain is hydro-
phobic. The presence of oxidized acyl chains destabilizes the hydrophobic core of the lipid
bilayer, forcing the phospholipids to adopt a new conformation. As the conformation of the
phospholipids affects the biophysical properties of the membrane, lipid peroxidation can affect
membrane fluidity, membrane thickness and acyl chain flexibility [21].
The biophysical properties of membranes significantly influence the behaviour of trans-
membrane (TM) proteins within the lipid bilayer. Indeed, changes to the lipid bilayer biophysi-
cal properties have been shown to affect the oligomeric state of single pass TM proteins,
independently of any ligand [22–24]. Oligomerization is both necessary and sufficient for
MAVS activation, suggesting that factors influencing its propensity to oligomerize could mod-
ulate MAVS signalling [25,26]. These considerations prompted us to test the hypothesis that
mROS-induced changes in the biophysical properties of the outer mitochondrial membrane
potentiate antiviral innate immune signalling by promoting MAVS TM domain oligomeriza-
tion through a simple biophysical principle.
Materials and Methods
Generation of Transgene Expressing Cells
A cDNA encoding a N-terminally FLAG-tagged mouse PERK kinase domain (amino acids
538–1113, numbering based onMus musculus PERK–Uniprot Q9Z2B5) (PERK-KD) fused to
MAVS Transmembrane Domain Oligomerization
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the C-terminal containing transmembrane domain of human MAVS (amino acids 509–540,
numbering based on Uniprot Q7Z434) (MAVS-TM) was synthesized by Genscript and cloned
into the pCDNA5_FRT_TO plasmid (Invitrogen) to generate the FLAG_PERK-KD_
MAVS-TM expression plasmid. A cDNA encoding the C-terminal containing transmembrane
domain of the outer mitochondrial outer membrane protein 25 (OMP25-TM) (amino acids
109–145, numbering based on Uniprot P57105) was synthesized by Genscript and cloned into
pCDNA5_FRT_TO_FLAG_PERK-KD_MAVS-TM to exchange the TM domain of MAVS
with the TM domain of OMP25 and to generate FLAG_PERK-KD_OMP25-TM expression
plasmid. These expression plasmids were co-transfected with the pOG44 plasmid (Invitrogen)
into Flp-In T-Rex-293 cells (Invitrogen) to generate isogenic cells expressing the transgene
under a doxycycline inducible promoter. Stable clones were selected by blasticidin selection.
The cytosolic Fv2E-PERK construct and the generation of Fv2E-PERK expressing cells was
previously described [27].
Cell Treatments and Viral Infections
Cells were treated with rotenone, antimycin A, hydrogen peroxide at the doses and for the time
indicated in the figure legends. Cells were treated with poly(I:C) complexed to the transfection
reagent Lyovec (poly(I:C)/Lyovec, Invivogen) as described in the figure legends. Cells were
infected with 100HA/ml of Sendai virus strain Cantell, obtained from Charles River laborato-
ries. Infection was started in 10cm dishes with inoculation for 1h with virus diluted in 2ml
DMEM, followed by removal of the inoculum and addition of DMEMmedium containing
10% serum and antibiotics. Transgene expression was always induced by treatment with
100μM doxycycline for a period of 90min ending at the moment of cell harvest.
Immunoprecipitation and Immunoblotting
Cells were lysed as previously described [28]. Anti-Flag affinity gel (Sigma) was used to immu-
noprecipitate Flag-tagged proteins followed by immunoblotting with mouse monoclonal anti-
body Flag M2 (Sigma). In vitro dephosphorylation was performed on immunoprecipitation
beads with purified bacterially-expressed lambda phosphatase.
Quantitative Reverse Transcription PCR (q-RT-PCR)
RNA was collected with a RNeasy Mini kit (Qiagen). RNA for human CXCL10, IFN-β and β-
actin was analysed with premade Taqman Gene Expression Assay primers and probes (Applied
Biosystems) and an RNA-to-CT 1-step kit (Applied Biosystems).
ROS Detection by Flow Cytometry
Cells were treated as indicated in the figure legends and stained 30min before harvest with
2.5μMMitoSOX Red superoxide indicator (Invitrogen) at 37°C in a 5% CO2 incubator. Cells
were then washed with phosphate buffered saline, trypsinized and processed for flow cytometry
analysis.
Confocal Microscopy
Cells were stained with the mitochondrial specific marker MitoTracker Red CMXRos (Invitro-
gen) and then fixed and processed for immunofluorescence as previously described [29]. Cells
were stained with the mouse monoclonal antibody Flag M2 (Sigma) and secondary anti-mouse
Dye Light 488. Images were taken on a Zeiss Meta 510 confocal microscope using sequential
acquisition.
MAVS Transmembrane Domain Oligomerization
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Measurement of Lipid Peroxidation
Lipid peroxidation was measured with the Thiobarbituric Acid Reactive Substances (TBARS)
assay (Cayman) according to the manufacturer’s protocol.
Statistical Analysis
Statistical significance for poly(I:C) and rotenone treatment effects was determined by one-way
analysis of variance with post-hoc Bonferroni test. Statistical significance for Sendai virus time-
dependent effects was determined by one-way analysis of variance with post-hoc Dunnett’s test
defining time 0h as the reference control group. Statistical significance for comparisons between
treated and non-treated samples in the TBARS assay was determined with Mann-Whitney test.
Results
To explore the consequences of increased mROS production on type I IFN responses, we
treated the human HEK 293T cell line with rotenone [30]. Inhibition of mitochondrial respira-
tory chain complex I by rotenone enhanced mROS production, as reflected by increased Mito-
SOX staining (S1 Fig). When used alone, neither rotenone (at 1μM for 16h), nor the RLR
ligand poly(I:C)-LyoVec (poly(I:C)-LV) (at 0.1μg/ml) led to increased IFN-β transcription (Fig
1A). By contrast, treatment of cells with both rotenone and 0.1μg/ml poly(I:C)-LV led to a five
fold increase in IFN-β transcription (compared to cells treated with 0.1μg/ml poly(I:C)-LV
alone), reaching IFN-β transcript levels similar to those observed in cells treated with 10 fold
higher concentration of poly(I:C)-LV (1μg/ml) alone. Rotenone did not measurably increase
IFN-βmRNA levels beyond those observed in cells treated with 1μg/ml poly(I:C)-LV, suggest-
ing that IFNβ transcription had already reached a maximum. Similar upregulation of the che-
mokine CXCL10 transcripts were found in cells co-treated with rotenone and 0.1μg/ml poly(I:
C)-LV (Fig 1B). CXCL10 is upregulated directly by PAMP receptor signalling and IRF3 medi-
ated transcriptional activation or by type I IFN signalling [31]. These results indicate that rote-
none potentiates RLR signalling only when submaximal concentrations of RLR ligands are
present, leading to increased transcription of type I IFN.
To test if increased mROS production could promote MAVS-TM domain oligomerization,
we engineered a chimeric protein formed by the N-terminally FLAG-tagged catalytic domain
of the endoplasmic reticulum stress kinase PERK (PERK-KD) fused to the transmembrane
domain (TM) of MAVS (Flag_PERK-KD_MAVS-TM, Fig 2A). Oligomerization of the kinase
domain of the endoplasmic reticulum stress transducer PERK promotes autophosphorylation,
which is readily detectable on a SDS-PAGE gel by the appearance of slower migrating bands
corresponding to phosphorylated forms of the protein [32]. When PERK-KD is fused to a TM
domain, changes in the lipid membrane composition have been shown to cause lipid-depen-
dent phosphorylation of PERK-KD that is driven by TM-domain oligomerization [24]. We
therefore anticipated that PERK-KD fused to MAVS-TM domain would serve as a sensitive
reporter on MAVS-TM domain oligomerization should it occur in response to changes in the
outer mitochondrial membrane biophysical properties.
Single copies of Flag_PERK-KD_MAVS-TM were introduced by recombination into a spe-
cific genomic location of the Flp-In T-Rex-293 cell line. Flp-In T-Rex-293 cells also contain a
Tet-ON inducible system to control the expression of the transgene. Following doxycycline
induction, Flag_PERK-KD_MAVS-TM colocalized with the mitochondrial staining dye Mito-
Tracker, indicating that the TM domain of MAVS targeted the Flag_PERK-KD_MAVS-TM
protein to the mitochondria (Fig 2B). Following 90min treatment with rotenone, we observed a
dose-dependent appearance of heterogeneous slower migrating bands of Flag_PERK-KD_
MAVS-TM, which appeared most intense with 10 μM rotenone (Fig 2C, top panel). In vitro
MAVS Transmembrane Domain Oligomerization
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treatment with lambda phosphatase collapsed the heterogeneous slower-migrating bands of
Flag_PERK-KD_MAVS-TM into a faster migrating band, confirming that the former repre-
sented autophosphorylated active PERK (Fig 2C, bottom panel). Time-course analysis revealed
that Flag_PERK-KD_MAVS-TM phosphorylation was readily detected 30min after rotenone
treatment and similar observations were made following treatment with antimycin A (Fig 2D);
an inhibitor of the mitochondrial respiratory chain complex III that also increased mROS levels
(S1 Fig) [33].
The isolated PERK-KD is enzymatically-active in vitro [32], raising the possibility that a dif-
fusible signal(s) generated in rotenone treated cells might directly contribute to activation of
the PERK kinase domain (independently of membrane anchoring via the TM domain). To test
this possibility, we expressed FV2E-PERK, a previously characterized cytosolic fusion protein
Fig 1. Rotenone potentiates RLR signalling. HEK 293T cells were treated with 1 μM rotenone alone or in
combination with 0.1 μg/ml or 1 μg/ml of the intracellularly delivered RLR ligand poly(I:C)/Lyovec (poly(I:C)-
LV) for 16h. (A) IFNβmRNA levels and (B) CXCL10 mRNA levels were quantified by qRT-PCR and
normalized to the level of β actin mRNA. Shown are the mean ± standard error of the mean (sem) of three
independent experiments. *, p 0.05
doi:10.1371/journal.pone.0136883.g001
MAVS Transmembrane Domain Oligomerization
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Fig 2. Increased MAVS-TM domain oligomerization in cells with elevated reactive oxygen species. (A)
Schema of Flag_PERK-KD_MAVS-TM, a N-terminally Flag-tagged fusion protein between the kinase
domain of PERK and the TM domain of MAVS. The construct encoding this protein was introduced into Flp-In
T-Rex-293 cells by recombination (B) Intracellular localization of Flag_PERK-KD_MAVS-TM following
doxycycline induction in Flp-In T-Rex-293 cells. Cells were stained for the Flag tag and the mitochondrial
specific dye MitoTracker. Images were acquired sequentially on a confocal microscope. The merge panel
MAVS Transmembrane Domain Oligomerization
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between PERK-KD and a modified FK506 binding domain (Fv2E) that undergoes ligand-
induced activation [27]. Treatment with the dimerizing ligand AP20187 caused Fv2E-PERK
phosphorylation, reflected in a shift in its mobility (Fig 2E). However, the cytosolic Fv2E-PERK
was unresponsive to rotenone and antimycin A treatment. As FV2E-PERK lacks a TM domain
and is cytosolic, these results demonstrate that Flag_PERK-KD_MAVS-TM phosphorylation
requires membrane tethering via a TM domain and is likely mediated by mROS-induced
changes in the outer mitochondrial membrane lipid bilayer properties and not by a diffusible
signal. As PERK-KD autophosphorylation requires oligomerization, these results indicate that
mROS inducers cause lipid-dependent MAVS-TM oligomerization [34]. In agreement with a
role of ROS in triggering lipid-dependent MAVS-TM oligomerization, treatment with hydro-
gen peroxide (H2O2) also led to Flag_PERK-KD_MAVS-TM phosphorylation (Fig 2F).
Increased mROS production has been observed in virus-infected cells [35–37], prompting
us to analyse whether ROS-mediated lipid membrane modifications correlate with Flag_
PERK-KD_MAVS-TM activation in virus-infected cells. Increased Flag_PERK-KD_MAVS-
TM phosphorylation was noted in cells infected with Sendai virus strain Cantell (Fig 3A) that
was associated with increased mROS production, as shown by MitoSOX staining (S1 Fig). As
FLAG_PERK-KD_MAVS-TM lacks the cytosolic domain of MAVS, it does not bind RIG-I
and MDA-5 and therefore reports on lipid-mediated MAVS TM domain-dependent oligomer-
ization in infected cells. The cytosolic fusion protein FV2E-PERK was not activated by Sendai
virus infection, demonstrating that TM domain-mediated membrane tethering is required for
Sendai virus-induced FLAG_PERK-KD_MAVS-TM activation (Fig 3C).
Sendai virus infection was associated with increased lipid peroxidation detected by the Thio-
barbituric Acid Reactive Substances (TBARS) assay (Fig 3D) [38]. TBARS were also elevated in
antimycin A, rotenone and H2O2-treated cells confirming that lipid peroxidation occurs under
these conditions. While we cannot exclude a role for other mitochondrial membrane modifica-
tions that might contribute to MAVS-TM oligomerization in Sendai virus infected cells, or in
cells treated with the mROS inducers rotenone and antimycin A, these observations are consis-
tent with a role for lipid peroxidation in stimulating MAVS-TM oligomerization.
To determine if rotenone and Sendai virus-induced TM oligomerization is restricted to the
TM domain of MAVS, we fused Flag_PERK-KD to the TM domain of OMP25, an unrelated
tail-anchored outer mitochondrial membrane resident protein (Fig 4A). We introduced this
construct by recombination in the Flp-In T-Rex-293 cell line and stimulated the expression of
the fusion protein by doxycycline induction. The fusion protein between Flag_PERK-KD and
OMP25 TM domain colocalized with the mitochondrial marker Mitotracker, confirming that
the OMP25 TM domain is able to target a fusion protein to the mitochondria [4] (Fig 4B). We
observed increased phosphorylation of PERK-KD fused to OMP25 TM domain in cells treated
with rotenone and in cells infected with Sendai virus, reflecting increased lipid-dependent olig-
omerization mediated by the OMP25 TM domain under these conditions (Fig 4C). Thus,
shows an overlap of Flag and Mitotracker signals. (C) Immunoblot of Flag_PERK-KD_MAVS-TM
immunopurified from Flp-In T-Rex-293 cells. Cells were either left untreated (non-induced) or exposed to
doxycycline to induce the expression of Flag_PERK-KD_MAVS-TM. In addition, cells were treated for 90min
with the indicated doses of rotenone. The position of hypophosphorylated (0) and phosphorylated (P)
Flag_PERK-KD_MAVS-TM is indicated in the top panel. The bottom panel is an immunoblot of the same
samples treated in vitro with λ-Phosphatase. (D) Immunoblot of Flag_PERK-KD_MAVS-TM immunopurified
from Flp-In T-Rex-293 cells treated with 10 μM rotenone or 40 μg/ml antimycin A for the indicated time. (E)
Immunoblot of Fv2E-PERK, immunopurified from cells treated with 10 μM rotenone (Rot) or 40 μg/ml
antimycin A (Ant A), or with the Fv2E-PERK dimerizing ligand AP20187 (AP) at 10 nM for 90 min. (F)
Immunoblot of Flag_PERK-KD_MAVS-TM immunopurified from Flp-In T-Rex-293 cells exposed for 2 hours
to the indicated concentrations of hydrogen peroxide. The percentage of PERK-KD phosphorylation is
indicated under each sample.
doi:10.1371/journal.pone.0136883.g002
MAVS Transmembrane Domain Oligomerization
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Fig 3. Sendai virus infection promotes lipid-dependent MAVS-TM domain oligomerization and
increases lipid peroxidation. (A) Immunoblot of Flag_PERK-KD_MAVS-TM immunopurified from Flp-In
T-Rex-293 cells infected with 100 HA/ml of Sendai virus strain Cantell for the indicated time. (B)
Quantification of the level of Flag_PERK-KD_MAVS-TM phosphorylation in Sendai virus-infected cells.
MAVS Transmembrane Domain Oligomerization
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lipid-dependent TM domain oligomerization is not restricted to MAVS-TM domain, suggest-
ing that rotenone treatment and Sendai virus infection induced changes in the OMM proper-
ties could modulate oligomerization of other mitochondrial proteins.
Discussion
MAVS-TM domain is shown here to oligomerize in response to changes in the outer mito-
chondrial lipid membrane properties caused by treatment with mROS inducers or by Sendai
virus infection. As MAVS oligomerization regulates its function, these results call attention to
the potential role of the outer mitochondrial lipid membrane properties as a modulator of
MAVS-mediated antiviral innate immune signalling.
The mROS inducer rotenone potentiated IFN-β and CXCL10 mRNA induction in
response to concomitant application of low concentrations of the RLR agonist poly(I:C)-LV.
Shown are mean ± sem values of three independent experiments. *, p 0.05; **, p 0.01 (C) Immunoblot
of Fv2E-PERK immunopurified from cells treated with 10 μM rotenone (Rot) for 90 min, or infected with 100
HA/ml Sendai virus for 16h (SeV), or treated with the Fv2E-PERK dimerizing ligand AP20187 (AP) at 10 nM
for 90 min. The percentage of Fv2E-PERK phosphorylation is indicated under each sample. (D) Detection of
lipid peroxidation end products by the Thiobarbituric Acid Reactive Substances (TBARS) assay. Pure
malondialdehyde was used as a reference in the assay. TBARS were quantified from Flp-In T-Rex-293 cells
treated for 90min with 40 μg/ml Antimycin A, 10 μMRotenone, 1 mM hydrogen peroxide, or infected with 100
HA/ml Sendai virus for 16 hours. Shown is a representative experiment reproduced three times. Data are
mean ± sem values of two technical replicates, each analysed in triplicate. *, p 0.05; **, p 0.01
doi:10.1371/journal.pone.0136883.g003
Fig 4. Rotenone and Sendai virus infection trigger oligomerization of the TM domain of the unrelated
outer mitochondrial membrane protein OMP25. (A) Schema of Flag_PERK-KD_OMP25-TM, a N-
terminally Flag-tagged fusion protein between the kinase domain of PERK and the TM domain of OMP25, an
outer mitochondrial membrane protein. The construct encoding this protein was introduced into Flp-In T-Rex-
293 cells by recombination (B) Intracellular localization of Flag_PERK-KD_OMP25-TM following doxycycline
induction in Flp-In T-Rex-293 cells. Cells were stained for the Flag tag and the mitochondrial specific dye
MitoTracker. Images were acquired sequentially on a confocal microscope. The merge panel shows an
overlap of Flag and Mitotracker signals. (C) Immunoblot of Flag_PERK-KD fused to the TM domain of MAVS
(MAVS-TM) or to the TM domain of OMP25 (OMP25-TM). Cells were treated with 10 μM rotenone (Rot) for
90 min, or infected with 100 HA/ml Sendai virus for 16h (SeV). The percentage of PERK-KD phosphorylation
is indicated under each sample.
doi:10.1371/journal.pone.0136883.g004
MAVS Transmembrane Domain Oligomerization
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Interestingly, when applied alone rotenone was insufficient to activate type I IFNs transcription
but was able to activate an oligomerization reporter construct (Flag_PERK-KD_MAVS-TM)
localised to the outer mitochondrial membrane. Both events are dependent on oligomerization
of their respective effector: Oligomerization of the cytosolic CARD domain of MAVS promotes
downstream signalling to the IFNs genes, whereas oligomerization of PERK kinase domain is
required for autophosphorylation in the chimeric reporter. The differences between the
responses of the two are consistent with different thresholds of sensitivity to the oligomer-
monomer equilibrium, with the MAVS requiring sustained oligomerization reinforced by con-
comitant RLR binding to trigger downstream signalling. Thus mROS inducers favour
MAVS-TM oligomerization but at a level that is insufficient to cause the sustained MAVS
CARD domain interaction needed for downstream signalling [39]. Nonetheless, our findings
suggest that mROS-induced lipid-dependent MAVS TM domain oligomerization could lower
the threshold of RLR ligand required for MAVS CARD homodimerization or homooligomeri-
zation and therefore prime MAVS for signalling (Fig 5).
The endoplasmic reticulum lipid membrane properties have been shown to modulate sig-
nalling by the unfolded protein response (UPR) transducers, IRE1 and PERK [24,40,41]. Lipid
modifications triggered oligomerization of IRE1 and PERK TM domains, as observed here for
MAVS-TM domain, indicating that lipid-dependent TM domain oligomerization may be a
conserved mechanism modulating TM protein function. Changes in the lipid membrane
Fig 5. Proposedmodel for mROS effects on MAVS signalling.MAVS is predominantly monomeric on the outer mitochondrial membrane of cells with low
levels of mROS (top panel). Increased mROS production promotes lipid-dependent oligomerization of MAVS TM domain (lower panel). Upon viral infection,
RLRs bind to viral RNA and expose their CARD domain, which is now available to interact with the CARD domain of MAVS. RLR induced MAVS CARD
domains homo-oligomerization is required for MAVS signalling. Lipid-dependent TM domain oligomerization could prime MAVS for RLR-induced MAVS
CARD domains homooligomerization, therefore leading to increased MAVS signalling.
doi:10.1371/journal.pone.0136883.g005
MAVS Transmembrane Domain Oligomerization
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properties causing TM domain-dependent oligomerization synergize with concomitant
lumenal (unfolded protein) or cytosolic (RLR) oligomerizing signals to promote downstream
signalling to effectors. However, the UPR transducers have a lower threshold of sensitivity to
the oligomer-monomer equilibrium than MAVS, with PERK and IRE1 being able to respond
to changes in the endoplasmic reticulum lipid composition independently of any concomitant
lumenal unfolded protein signal [24].
Oligomerization was observed for the TM domain of MAVS and OMP25, which are two
unrelated TM peptides that have a similar hydrophobicity profile, but that to our knowledge
do not share any noticeable common peptide motif. As the amino acids constituting the TM
domain seemed to have a minor role in conferring responsiveness to rotenone or Sendai virus
induced lipid modifications, oligomerization is not likely to rely on specific peptide-lipid inter-
actions, bur rather relies primarily on changes in the biophysical properties of the lipid mem-
brane. Changes in the lipid bilayer biophysical properties known to modulate TM domain
oligomerization include modifications of the thickness of the lipid bilayer, changes in mem-
brane fluidity and acyl chain flexibility. These lipid bilayer biophysical properties affect the
strength of the interaction between TM amino acid side chains and the surrounding lipids.
When the strength of the peptide-lipid interaction decreases, polar amino acids embedded in
the lipid bilayer are no longer solvated as efficiently by surrounding lipids, creating a thermo-
dynamically unfavourable situation that can be relieved by the interaction between amino acid
side chains from TM peptides [42]. This generic mechanism can promote TM-TM interactions
in response to changes in the biophysical properties of the membrane. At present, the nature of
the changes in the OMM biophysical properties occurring in cells treated with mROS inducers
or in Sendai virus infected cells remain to be characterized.
The mitochondrial phospholipid composition has been extensively studied and reviewed
[43–45]. In addition to the most prevalent phospholipids phosphatidylcholine and phosphati-
dylethanolamine, mitochondria contain the mitochondria specific phospholipid cardiolipin,
which accounts for around 15–20% of total mitochondrial phospholipids. Cardiolipins accu-
mulate in the inner mitochondrial membrane (IMM). The proportion of cardiolipin in the
OMM ranges from trace amounts to around 25% of total cardiolipins depending on the studies
[43,46]. This variability is in part due to the technically challenging differential purification of
IMM and OMM. The mitochondrial lipid membrane properties are also determined by the
acyl chain length and degree of unsaturation within each phospholipid class. Cardiolipins have
a high degree of acyl-chain unsaturation, rendering them highly susceptible to ROS-mediated
oxidation. The acyl chain composition of the other mitochondrial phospholipids remains
poorly defined. When the phospholipid class is not considered, total mitochondrial phospho-
lipids have around 14% of mono unsaturated acyl chains and around 49% of polyunsaturated
acyl chains irrespective of the phospholipid class [43]. The relative proportions in the IMM
and OMM are not known, but it is thought that unequal repartition of phospholipid classes
and acyl chains between the IMM and the OMM are important for maintaining a smooth
OMM and a folded less fluid IMM [45]. Even within the mitochondrial membranes, lipid dis-
tribution is heterogeneous, as observed in the cardiolipin rich cristae tips or in the mitochon-
drial-associated membranes microdomains [44], which are contact sites between the ER and
the OMM recently involved in antiviral signalling [5]. Alterations in the lipid composition can
impact mitochondrial membrane protein function and the regulation of mitochondrial mor-
phology and dynamics. Treatment with rotenone has been associated with the oxidation of
mitochondrial lipids [47], but also with alterations in mitochondrial lipids distribution [48]
and with changes in the mitochondrial morphology [49]. All these changes could potentially
occur in mROS inducers-treated cells or in Sendai virus-infected cells and trigger changes to
MAVS Transmembrane Domain Oligomerization
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the biophysical properties of the OMM. Further work is required to determine which changes
to the mitochondrial lipid properties cause MAVS-TM oligomerization.
Viruses rely on host cell metabolism for their replication. As a consequence, they are
unlikely to develop resistance to or bypass the consequences of processes such as metabolism-
induced ROS production that are linked to pathways needed for their replication. Thus, identi-
fying ways to manipulate cellular metabolism to increase mROS production specifically in
infected cells could be a promising approach to promote antiviral signalling. This could com-
plement conventional PAMP detection mechanisms to strengthen the innate immune response
by taking advantage of the specific metabolic requirements of a virus in a host cell.
Supporting Information
S1 Fig. Mitochondrial ROS production.Histogram of MitoSOX fluorescent signal from
untreated Flp-In T-Rex-293 cells (blue curve) and cells treated for 90min with 10 μM rotenone
(yellow curve), 40 μg/ml antimycin A (green curve), or infected with 16h with Sendai virus
(orange curve). Cells were stained with MitoSOX and analysed by flow cytometry.
(TIF)
Acknowledgments
We are grateful to Mike Murphy (MRCMitochondrial Biology Unit, Cambridge, United King-
dom) for insightful discussions during the course of this project.
Author Contributions
Conceived and designed the experiments: DR RV. Performed the experiments: LN DW RV.
Analyzed the data: LN DWDR RV. Wrote the paper: DR RV.
References
1. Pandey S, Kawai T, Akira S. Microbial Sensing by Toll-Like Receptors and Intracellular Nucleic Acid
Sensors. Cold Spring Harb Perspect Biol. 2015; 7: a016246. doi: 10.1101/cshperspect.a016246
2. Wu B, Peisley A, Tetrault D, Li Z, Egelman EH, Magor KE, et al. Molecular imprinting as a signal-activa-
tion mechanism of the viral RNA sensor RIG-I. Mol Cell. 2014; 55: 511–523. doi: 10.1016/j.molcel.
2014.06.010 PMID: 25018021
3. Hou F, Sun L, Zheng H, Skaug B, Jiang Q-X, Chen ZJ. MAVS Forms Functional Prion-like Aggregates
to Activate and Propagate Antiviral Innate Immune Response. Cell. 2011; 146: 448–461. doi: 10.1016/j.
cell.2011.06.041 PMID: 21782231
4. Dixit E, Boulant S, Zhang Y, Lee ASY, Odendall C, Shum B, et al. Peroxisomes are signaling platforms
for antiviral innate immunity. Cell. 2010; 141: 668–681. doi: 10.1016/j.cell.2010.04.018 PMID:
20451243
5. Horner SM, Liu HM, Park HS, Briley J, Gale M. Mitochondrial-associated endoplasmic reticulummem-
branes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci.
2011; 108: 14590–14595. doi: 10.1073/pnas.1110133108 PMID: 21844353
6. Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, et al. Diverse intracellular pathogens
activate type III interferon expression from peroxisomes. Nat Immunol. 2014; 15: 717–726. doi: 10.
1038/ni.2915 PMID: 24952503
7. Castanier C, Garcin D, Vazquez A, Arnoult D. Mitochondrial dynamics regulate the RIG-I-like receptor
antiviral pathway. EMBORep. 2010; 11: 133–138. doi: 10.1038/embor.2009.258 PMID: 20019757
8. Onoguchi K, Onomoto K, Takamatsu S, Jogi M, Takemura A, Morimoto S, et al. Virus-Infection or
50ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1. PLoS Pathog.
2010; 6: e1001012. doi: 10.1371/journal.ppat.1001012 PMID: 20661427
9. Yasukawa K, Oshiumi H, Takeda M, Ishihara N, Yanagi Y, Seya T, et al. Mitofusin 2 inhibits mitochon-
drial antiviral signaling. Sci Signal. 2009; 2: ra47. doi: 10.1126/scisignal.2000287 PMID: 19690333
MAVS Transmembrane Domain Oligomerization
PLOS ONE | DOI:10.1371/journal.pone.0136883 August 28, 2015 12 / 14
10. Koshiba T, Yasukawa K, Yanagi Y, Kawabata S. Mitochondrial membrane potential is required for
MAVS-mediated antiviral signaling. Sci Signal. 2011; 4: ra7. doi: 10.1126/scisignal.2001147 PMID:
21285412
11. Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim K-Y, et al. Mitochondrial reactive oxygen spe-
cies promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic
syndrome (TRAPS). J Exp Med. 2011; 208: 519–533. doi: 10.1084/jem.20102049 PMID: 21282379
12. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J
Exp Med. 2011; 208: 417–420. doi: 10.1084/jem.20110367 PMID: 21357740
13. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A. Absence of autophagy results in reactive
oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci. 2009; 106: 2770–2775.
doi: 10.1073/pnas.0807694106 PMID: 19196953
14. Zhao Y, Sun X, Nie X, Sun L, Tang T, Chen D, et al. COX5B Regulates MAVS-mediated Antiviral Sig-
naling through Interaction with ATG5 and Repressing ROS Production. PLoS Pathog. 2012; 8:
e1003086. doi: 10.1371/journal.ppat.1003086 PMID: 23308066
15. Sena LA, Chandel NS. Physiological Roles of Mitochondrial Reactive Oxygen Species. Mol Cell. 2012;
48: 158–167. doi: 10.1016/j.molcel.2012.09.025 PMID: 23102266
16. DrögeW. Free Radicals in the Physiological Control of Cell Function. Physiol Rev. 2002; 82: 47–95.
doi: 10.1152/physrev.00018.2001 PMID: 11773609
17. Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr Opin Cell Biol. 2015; 33: 8–13. doi:
10.1016/j.ceb.2014.09.010 PMID: 25305438
18. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, et al. ROS-dependent activa-
tion of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat
Immunol. 2005; 6: 587–592. doi: 10.1038/ni1200 PMID: 15864310
19. Gonzalez-Dosal R, Horan KA, Rahbek SH, Ichijo H, Chen ZJ, Mieyal JJ, et al. HSV Infection Induces
Production of ROS, which Potentiate Signaling from Pattern Recognition Receptors: Role for S-glu-
tathionylation of TRAF3 and 6. PLoS Pathog. 2011; 7: e1002250. doi: 10.1371/journal.ppat.1002250
PMID: 21949653
20. Reis A, Spickett CM. Chemistry of phospholipid oxidation. Biochim Biophys Acta. 2012; 1818: 2374–
2387. doi: 10.1016/j.bbamem.2012.02.002 PMID: 22342938
21. Wallgren M, Beranova L, PhamQD, Linh K, LidmanM, Procek J, et al. Impact of oxidized phospholipids
on the structural and dynamic organization of phospholipid membranes: a combined DSC and solid
state NMR study. Faraday Discuss. 2013; 161: 499–513; discussion 563–589. PMID: 23805755
22. Mall S, Broadbridge R, Sharma RP, East JM, Lee AG. Self-association of model transmembrane alpha-
helices is modulated by lipid structure. Biochemistry (Mosc). 2001; 40: 12379–12386.
23. Anbazhagan V, Schneider D. The membrane environment modulates self-association of the human
GpA TM domain—implications for membrane protein folding and transmembrane signaling. Biochim
Biophys Acta. 2010; 1798: 1899–1907. doi: 10.1016/j.bbamem.2010.06.027 PMID: 20603102
24. Volmer R, Ploeg K van der, Ron D. Membrane lipid saturation activates endoplasmic reticulum
unfolded protein response transducers through their transmembrane domains. Proc Natl Acad Sci.
2013; 110: 4628–4633. doi: 10.1073/pnas.1217611110 PMID: 23487760
25. Baril M, Racine M-E, Penin F, Lamarre D. MAVS Dimer Is a Crucial Signaling Component of Innate
Immunity and the Target of Hepatitis C Virus NS3/4A Protease. J Virol. 2009; 83: 1299–1311. doi: 10.
1128/JVI.01659-08 PMID: 19036819
26. Tang ED, Wang C-Y. MAVS Self-Association Mediates Antiviral Innate Immune Signaling. J Virol.
2009; 83: 3420–3428. doi: 10.1128/JVI.02623-08 PMID: 19193783
27. Lu PD, Jousse C, Marciniak SJ, Zhang Y, Novoa I, Scheuner D, et al. Cytoprotection by pre‐emptive
conditional phosphorylation of translation initiation factor 2. EMBO J. 2004; 23: 169–179. doi: 10.1038/
sj.emboj.7600030 PMID: 14713949
28. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress
transducers in the unfolded-protein response. Nat Cell Biol. 2000; 2: 326–332. doi: 10.1038/35014014
PMID: 10854322
29. Volmer R, Mazel-Sanchez B, Volmer C, Soubies SM, Guérin J-L. Nucleolar localization of influenza A
NS1: striking differences between mammalian and avian cells. Virol J. 2010; 7: 63. doi: 10.1186/1743-
422X-7-63 PMID: 20236536
30. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial Complex I Inhibitor
Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production.
J Biol Chem. 2003; 278: 8516–8525. doi: 10.1074/jbc.M210432200 PMID: 12496265
MAVS Transmembrane Domain Oligomerization
PLOS ONE | DOI:10.1371/journal.pone.0136883 August 28, 2015 13 / 14
31. Nakaya T, Sato M, Hata N, Asagiri M, Suemori H, Noguchi S, et al. Gene Induction Pathways Mediated
by Distinct IRFs during Viral Infection. Biochem Biophys Res Commun. 2001; 283: 1150–1156. doi: 10.
1006/bbrc.2001.4913 PMID: 11355893
32. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-
resident kinase. Nature. 1999; 397: 271–274. doi: 10.1038/16729 PMID: 9930704
33. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of Reactive Oxygen Spe-
cies by Mitochondria CENTRAL ROLE OF COMPLEX III. J Biol Chem. 2003; 278: 36027–36031. doi:
10.1074/jbc.M304854200 PMID: 12840017
34. Dey M, Cao C, Sicheri F, Dever TE. Conserved Intermolecular Salt Bridge Required for Activation of
Protein Kinases PKR, GCN2, and PERK. J Biol Chem. 2007; 282: 6653–6660. doi: 10.1074/jbc.
M607897200 PMID: 17202131
35. Deng L, Shoji I, OgawaW, Kaneda S, Soga T, Jiang D, et al. Hepatitis C virus infection promotes
hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol. 2011; 85:
8556–8568. doi: 10.1128/JVI.00146-11 PMID: 21697492
36. Mukherjee P, Woods TA, Moore RA, Peterson KE. Activation of the innate signaling molecule MAVS by
bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity.
2013; 38: 705–716. doi: 10.1016/j.immuni.2013.02.013 PMID: 23499490
37. Ichinohe T, Yamazaki T, Koshiba T, Yanagi Y. Mitochondrial protein mitofusin 2 is required for NLRP3
inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A. 2013; 110: 17963–
17968. doi: 10.1073/pnas.1312571110 PMID: 24127597
38. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978; 52: 302–310. PMID:
672633
39. Liu S, Chen J, Cai X, Wu J, Chen X, Wu Y-T, et al. MAVS recruits multiple ubiquitin E3 ligases to acti-
vate antiviral signaling cascades. eLife. 2013; 2: e00785. doi: 10.7554/eLife.00785 PMID: 23951545
40. Promlek T, Ishiwata-Kimata Y, Shido M, Sakuramoto M, Kohno K, Kimata Y. Membrane aberrancy and
unfolded proteins activate the endoplasmic reticulum stress sensor Ire1 in different ways. Mol Biol Cell.
2011; 22: 3520–3532. doi: 10.1091/mbc.E11-04-0295 PMID: 21775630
41. Volmer R, Ron D. Lipid-dependent regulation of the unfolded protein response. Curr Opin Cell Biol.
2015; 33: 67–73. doi: 10.1016/j.ceb.2014.12.002 PMID: 25543896
42. Li E, Wimley WC, Hristova K. Transmembrane Helix Dimerization: Beyond the Search for Sequence
Motifs. Biochim Biophys Acta. 2012; 1818: 183–193. doi: 10.1016/j.bbamem.2011.08.031 PMID:
21910966
43. DaumG, Vance JE. Import of lipids into mitochondria. Prog Lipid Res. 1997; 36: 103–130. doi: 10.
1016/S0163-7827(97)00006-4 PMID: 9624424
44. Osman C, Voelker DR, Langer T. Making heads or tails of phospholipids in mitochondria. J Cell Biol.
2011; 192: 7–16. doi: 10.1083/jcb.201006159 PMID: 21220505
45. Horvath SE, DaumG. Lipids of mitochondria. Prog Lipid Res. 2013; 52: 590–614. doi: 10.1016/j.
plipres.2013.07.002 PMID: 24007978
46. Gebert N, Joshi AS, Kutik S, Becker T, McKenzie M, Guan XL, et al. Mitochondrial Cardiolipin Involved
in Outer-Membrane Protein Biogenesis: Implications for Barth Syndrome. Curr Biol. 2009; 19: 2133–
2139. doi: 10.1016/j.cub.2009.10.074 PMID: 19962311
47. Tyurina YY, Polimova AM, Maciel E, Tyurin VA, Kapralova VI, Winnica DE, et al. LC/MS analysis of car-
diolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunc-
tion in Parkinson’s disease. Free Radic Res. 2015; 49: 681–691. doi: 10.3109/10715762.2015.
1005085 PMID: 25740198
48. Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, et al. Cardiolipin externalization to the
outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell
Biol. 2013; 15: 1197–1205. doi: 10.1038/ncb2837 PMID: 24036476
49. Gottlieb E, Armour SM, Harris MH, Thompson CB. Mitochondrial membrane potential regulates matrix
configuration and cytochrome c release during apoptosis. Cell Death Differ. 2003; 10: 709–717. doi: 10.
1038/sj.cdd.4401231 PMID: 12761579
MAVS Transmembrane Domain Oligomerization
PLOS ONE | DOI:10.1371/journal.pone.0136883 August 28, 2015 14 / 14
